Eledon Pharmaceuticals (ELDN) Institutional Ownership $4.02 -0.01 (-0.25%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Eledon Pharmaceuticals (NASDAQ:ELDN)CurrentInstitutional OwnershipPercentage56.77%Number ofInstitutional Buyers(last 12 months)11TotalInstitutional Inflows(last 12 months)$4.20MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$1.68M Get ELDN Insider Trade Alerts Want to know when executives and insiders are buying or selling Eledon Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ELDN Institutional Buying and Selling by Quarter Eledon Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/17/2025 Inspire Investing LLC194,688$802K0.1%N/A0.326% 1/15/2025 Kera Capital Partners Inc.25,770$106K0.0%N/A0.043% 11/16/2024Geode Capital Management LLC378,058$942K0.0%+9.7%0.953% 11/15/2024Zimmer Partners LP1,434,727$3.57M0.1%-32.0%3.618% 10/30/2024Clarity Capital Partners LLC11,500$29K0.0%N/A0.029% 8/20/2024Nantahala Capital Management LLC600,000$1.58M0.1%N/A2.418% 8/15/2024Armistice Capital LLC2,336,000$6.17M0.1%+1.7%9.414% 8/9/2024Renaissance Technologies LLC136,773$361K0.0%+57.1%0.551% 8/9/2024Dimensional Fund Advisors LP30,233$80K0.0%N/A0.122% 8/8/2024Marco Investment Management LLC30,344$80K0.0%+22.3%0.122% Get the Latest News and Ratings for ELDN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eledon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 5/14/2024CM Management LLC160,000$330K0.3%+14.3%0.645% 5/10/2024Vanguard Group Inc.969,121$2.00M0.0%+39.4%3.906% 2/13/2024Armistice Capital LLC2,189,000$3.94M0.1%+20.0%9.045% 11/15/2023Armistice Capital LLC1,824,000$2.50M0.0%-1.0%7.538% 10/19/2023Jmac Enterprises LLC58,041$80K0.0%-27.5%0.246% 8/15/2023BVF Inc. IL4,326,710$5.93M0.2%+86.0%18.372% 8/11/2023SVB Financial Group18,025$25K0.0%-33.1%0.080% 7/20/2023Jmac Enterprises LLC80,041$110K0.0%+46.8%0.356% 2/9/2023CM Management LLC234,800$535K0.6%-4.2%1.706% 11/14/2022Cormorant Asset Management LP1,223,500$3.38M0.2%-6.3%8.894% 11/14/2022Point72 Asset Management L.P.375,000$1.04M0.0%-12.5%2.726% 11/14/2022Boothbay Fund Management LLC22,050$61K0.0%-36.3%0.160% 11/4/2022CM Management LLC245,000$676K0.8%+8.9%1.781% 8/16/2022Woodline Partners LP516,675$1.26M0.0%-23.2%3.755% 5/9/2022CM Management LLC225,000$887K0.7%+95.7%1.636% 4/25/2022Bailard Inc.27,600$109K0.0%N/A0.193% 2/14/2022Point72 Asset Management L.P.431,435$1.90M0.0%+105.9%3.016% 2/11/2022Ensign Peak Advisors Inc77,100$340K0.0%+966.7%0.539% 2/7/2022 Ameritas Advisory Services LLC24,219$107K0.0%N/A0.169% 2/2/2022CM Management LLC115,000$507K0.4%+53.3%0.804% 11/16/2021Two Sigma Advisers LP115,900$716K0.0%+48.0%0.810% 11/16/2021Two Sigma Investments LP115,324$713K0.0%+100.5%0.806% 11/16/2021BVF Inc. IL1,363,435$8.43M0.3%+22.5%9.530% 11/15/2021Point72 Asset Management L.P.209,490$1.30M0.0%+11.0%1.464% 11/15/2021Eversept Partners LP114,008$705K0.1%N/A0.797% 11/15/2021Ensign Peak Advisors Inc7,228$45K0.0%-80.0%0.051% 11/10/2021Mercer Global Advisors Inc. ADV16,726$103K0.0%N/A0.117% 8/18/2021Ikarian Capital LLC350,000$2.77M0.2%+40.0%2.446% 8/17/2021Woodline Partners LP857,445$6.78M0.1%-3.8%5.993% 8/17/2021Boothbay Fund Management LLC40,052$317K0.0%+39.6%0.280% Do this Before Elon’s Reveal on January 22nd (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. 8/16/2021Point72 Asset Management L.P.188,690$1.49M0.0%+51.0%1.319% 8/16/2021Morgan Stanley851,004$6.73M0.0%+7,235.6%5.948% 8/16/2021State Street Corp32,935$261K0.0%N/A0.230% 8/13/2021Renaissance Technologies LLC21,107$167K0.0%-22.0%0.148% 8/13/2021Northern Trust Corp32,116$254K0.0%+106.8%0.224% 8/13/2021Geode Capital Management LLC124,614$985K0.0%+25.7%0.871% 8/13/2021Vanguard Group Inc.209,750$1.66M0.0%-8.8%1.466% 5/19/2021Logos Global Management LP224,071$2.40M0.2%N/A1.566% 5/18/2021BVF Inc. IL1,113,435$11.91M0.4%N/A7.782% 5/18/2021Millennium Management LLC14,588$156K0.0%N/A0.102% 5/18/2021Point72 Asset Management L.P.125,000$1.34M0.0%N/A0.874% 5/18/2021Cormorant Asset Management LP1,415,500$15.15M0.3%N/A9.894% 5/18/2021Citadel Advisors LLC25,062$268K0.0%N/A0.175% 5/17/2021Woodline Partners LP891,055$9.53M0.2%N/A6.228% 5/17/2021EcoR1 Capital LLC1,115,721$11.94M0.5%N/A7.798% 5/17/2021Janus Henderson Group PLC213,899$2.25M0.0%N/A1.495% 5/17/2021Ikarian Capital LLC250,000$2.68M0.1%N/A1.747% 5/13/2021Renaissance Technologies LLC27,051$289K0.0%N/A0.189% 5/12/2021Northern Trust Corp15,528$166K0.0%N/A0.109% 5/12/2021Geode Capital Management LLC99,123$1.06M0.0%N/A0.693% 5/12/2021CM Management LLC75,000$803K0.6%N/A0.524% 5/7/2021BlackRock Inc.12,282$131K0.0%N/A0.086% 4/21/2021Ingalls & Snyder LLC51,149$547K0.0%N/A0.358% (Data available from 1/1/2016 forward) ELDN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ELDN shares? During the previous two years, 15 institutional investors and hedge funds held shares of Eledon Pharmaceuticals. The most heavily invested institutionals were Armistice Capital LLC ($6.17M), BVF Inc. IL ($5.93M), Zimmer Partners LP ($3.57M), Vanguard Group Inc. ($2.00M), Nantahala Capital Management LLC ($1.58M), Geode Capital Management LLC ($942K), and Inspire Investing LLC ($802K).Learn more on ELDN's institutional investors. What percentage of Eledon Pharmaceuticals stock is owned by institutional investors? 56.77% of Eledon Pharmaceuticals stock is owned by institutional investors. Learn more on ELDN's institutional investor holdings. Which institutional investors have been buying Eledon Pharmaceuticals stock? Of the 13 institutional investors that purchased Eledon Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BVF Inc. IL ($2M), Nantahala Capital Management LLC ($600K), Armistice Capital LLC ($404K), Vanguard Group Inc. ($273.70K), Inspire Investing LLC ($194.69K), Renaissance Technologies LLC ($49.70K), and Geode Capital Management LLC ($33.57K). How much institutional buying is happening at Eledon Pharmaceuticals? Institutional investors have bought a total of 3,674,205 shares in the last 24 months. This purchase volume represents approximately $6.97M in transactions. Which Eledon Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Eledon Pharmaceuticals stock in the last 24 months: Zimmer Partners LP ($674.98K), Jmac Enterprises LLC ($22K), Armistice Capital LLC ($18.80K), CM Management LLC ($10.20K), and SVB Financial Group ($8.92K). How much institutional selling is happening at Eledon Pharmaceuticals? Institutional investors have sold a total of 734,897 shares in the last 24 months. This volume of shares sold represents approximately $1.77M in transactions. Related Companies PSTX Institutional Ownership OCS Institutional Ownership NUVB Institutional Ownership AVXL Institutional Ownership ABCL Institutional Ownership CVAC Institutional Ownership AVBP Institutional Ownership COGT Institutional Ownership PAHC Institutional Ownership RLAY Institutional Ownership This page (NASDAQ:ELDN) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eledon Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eledon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ELDN Stock Alerts